Precision medicine (PM) is a type of medicine that tries to enhance patient outcomes by stratifying or personalizing diagnosis and treatment decisions. Over the last few decades, a progressive trend toward patient-centered healthcare has made it possible to use tailored diagnostic and treatment approaches. Precision medicine (PM) delivers stratified patient subpopulations with known outcome margins with timely and cost-effective medical solutions. Genetic profiling, including the discovery of prognostic biomarkers, is now the most common form of PM intervention. These can identify people who are at risk for a particular disease or a severe form of a disease, allowing for early intervention to reduce disease burden and improve quality of life. Many factors influence the cost-effectiveness of targeted interventions, including the prevalence of a particular gene or allele in a population, the accuracy of a test, and the costs of testing and individualized treatment. As a result, patient outcomes may improve, although PM's cost-effectiveness is still unknown.
Title : The role of ATP as a Hydrotrope in health and disease
Jack V Greiner, Harvard Medical School, United States
Title : Precision treatment of alzheimer's
Boris Tankhilevich, Magtera, Inc., United States
Title : Modeling competition between subpopulations with variable DNA content in resource limited microenvironments
Noemi Andor, H. Lee Moffitt Cancer Center & Research Institute, United States
Title : Progesterone receptor pathways in preterm birth
Beverlee Wood, Case Western Reserve University, United States
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Monitoring folds localization in ultra-thin transition metal dichalcogenides using Optical Harmonic Generation
Ahmed Raza Khan, Australian National University, Australia